Zoryl-M2 Tablet PR is a combination of Glimepiride and Metformin used to treat type 2 diabetes mellitus. Metformin works by reducing glucose production in the liver and improving insulin sensitivity, while Glimepiride stimulates the pancreas to release more insulin. This extended-release formulation provides a consistent dose throughout the day, helping to maintain stable blood sugar levels. It is typically prescribed when diet and exercise alone are not enough to control blood sugar levels and is not suitable for type 1 diabetes.
Zoryl-M2 Tablet PR is not recommended for individuals with type 1 diabetes, as their bodies do not produce insulin, which is necessary for the medication to work effectively. It is also not recommended for individuals with diabetic ketoacidosis, which occurs when the body produces high levels of blood acids called ketones.
Like all medications, Zoryl-M2 Tablet PR may cause side effects in some individuals. However, if the side effects persist or become severe, it is essential to contact a healthcare provider immediately.